BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21911299)

  • 1. Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy.
    Bebes A; Nagy T; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M
    J Photochem Photobiol B; 2011 Nov; 105(2):162-6. PubMed ID: 21911299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition.
    Barron GA; Moseley H; Woods JA
    J Photochem Photobiol B; 2013 Sep; 126():87-96. PubMed ID: 23911860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.
    Ishikawa T; Kajimoto Y; Inoue Y; Ikegami Y; Kuroiwa T
    Adv Cancer Res; 2015; 125():197-216. PubMed ID: 25640271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
    Robey RW; Steadman K; Polgar O; Bates SE
    Cancer Biol Ther; 2005 Feb; 4(2):187-94. PubMed ID: 15684613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.
    Kim JH; Park JM; Roh YJ; Kim IW; Hasan T; Choi MG
    BMC Cancer; 2015 Jul; 15():504. PubMed ID: 26149077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
    Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.
    Ogino T; Kobuchi H; Munetomo K; Fujita H; Yamamoto M; Utsumi T; Inoue K; Shuin T; Sasaki J; Inoue M; Utsumi K
    Mol Cell Biochem; 2011 Dec; 358(1-2):297-307. PubMed ID: 21748335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy.
    Hagiya Y; Adachi T; Ogura S; An R; Tamura A; Nakagawa H; Okura I; Mochizuki T; Ishikawa T
    J Exp Ther Oncol; 2008; 7(2):153-67. PubMed ID: 18771089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
    Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.
    Ishikawa T; Kajimoto Y; Sun W; Nakagawa H; Inoue Y; Ikegami Y; Miyatake S; Kuroiwa T
    J Pharm Sci; 2013 Sep; 102(9):3058-69. PubMed ID: 23650051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
    Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
    Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
    Liu W; Baer MR; Bowman MJ; Pera P; Zheng X; Morgan J; Pandey RA; Oseroff AR
    Clin Cancer Res; 2007 Apr; 13(8):2463-70. PubMed ID: 17438106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines.
    Galetti M; Petronini PG; Fumarola C; Cretella D; La Monica S; Bonelli M; Cavazzoni A; Saccani F; Caffarra C; Andreoli R; Mutti A; Tiseo M; Ardizzoni A; Alfieri RR
    PLoS One; 2015; 10(11):e0141795. PubMed ID: 26536031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
    Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C.
    González-Lobato L; Real R; Prieto JG; Alvarez AI; Merino G
    Eur J Pharmacol; 2010 Oct; 644(1-3):41-8. PubMed ID: 20655304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs.
    Tamura A; Onishi Y; An R; Koshiba S; Wakabayashi K; Hoshijima K; Priebe W; Yoshida T; Kometani S; Matsubara T; Mikuriya K; Ishikawa T
    Drug Metab Pharmacokinet; 2007 Dec; 22(6):428-40. PubMed ID: 18159130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2.
    Robey RW; Fetsch PA; Polgar O; Dean M; Bates SE
    Res Vet Sci; 2006 Dec; 81(3):345-9. PubMed ID: 16808938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.
    Bram EE; Ifergan I; Grimberg M; Lemke K; Skladanowski A; Assaraf YG
    Biochem Pharmacol; 2007 Jun; 74(1):41-53. PubMed ID: 17481587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.